Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Sep 16, 2020 1:32pm
218 Views
Post# 31567973

CDC Say Covid-19 vaccine for public likely available in 2021

CDC Say Covid-19 vaccine for public likely available in 2021

Dr. Robert Redfield, director of the US Centers for Disease Control and Prevention, said during a Senate Appropriations subcommittee hearing on Wednesday that he thinks it will be the late second quarter or third quarter of 2021 before a Covid-19 vaccine is generally available to the American public. 

When asked when he thought there would be a vaccine ready to administer to the American public, Redfield said he thought that there would be vaccine initially available sometime between November and December, but “very limited supply and will have to be prioritized.” 

“If you’re asking me when is it going to be generally available to the American public, so we can begin to take advantage of vaccine to get back to our regular life, I think we’re probably looking at third, late second quarter, third quarter 2021.” 

Redfield said that he thought the vaccination would begin in November and December “and then will pick up, and it will be in a prioritized way. It will be those first responders and those at greatest risk for death, and then eventually that will expand.” 

https://www.cnn.com/world/live-news/coronavirus-pandemic-09-16-20-intl/index.html

<< Previous
Bullboard Posts
Next >>